Retractable Technologies (NYSE:RVP) vs. Motus GI (NASDAQ:MOTS) Critical Survey

Profitability

This table compares Retractable Technologies and Motus GI’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Motus GI	N/A	N/A	N/A

Valuation and Earnings

This table compares Retractable Technologies and Motus GI”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$38.16 million	0.64	-$7.01 million	($0.29)	-2.80
Motus GI	$319,000.00	0.00	-$12.87 million	($15.64)	N/A

Retractable Technologies has higher revenue and earnings than Motus GI. Retractable Technologies is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Retractable Technologies has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Motus GI has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500.

Insider & Institutional Ownership

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 20.1% of Motus GI shares are held by institutional investors. 57.1% of Retractable Technologies shares are held by company insiders. Comparatively, 0.3% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

About Retractable Technologies

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

About Motus GI

Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.